<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lee A</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>National Institute of Allergy and Infectious Diseases (NIAID)</funding><funding>NIAID NIH HHS</funding><funding>Ralph and Marian Falk Medical Research Catalyst Award</funding><funding>National Science Foundation</funding><pagination>85</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12853802</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(1)</volume><pubmed_abstract>Therapies for type 2 diabetes primarily target hyperglycemia; however, complications are also triggered by advanced glycation end products (AGEs). We hypothesize that the anti-diabetic efficacy of insulin-like growth factor-binding protein 4 (IGFBP4) is enhanced when it assembles with a specific amino acid compound-2 (AAC2) into nanostructures. Their effects were examined in vitro and in ob/ob mice treated for 30 days with the AAC2-IGFBP4 complex or its individual components. IGFBP4-mediated glucose uptake in human and mouse preadipocytes was enhanced by complex formation with AAC2. This complex was confirmed by Fourier-transform mid-infrared spectroscopy, electrophoresis, and AFM. In ob/ob mice, the complex prolonged IGFBP4 circulation and amplified the effects of the individual component</pubmed_abstract><journal>Journal of nanobiotechnology</journal><pubmed_title>Bidirectional regulation of liver sinusoidal clearance by amino acid nanofibers and IGFBP4 complex: effects on HbA1c.</pubmed_title><pmcid>PMC12853802</pmcid><funding_grant_id>AI170880</funding_grant_id><funding_grant_id>R56 AI170880</funding_grant_id><funding_grant_id>CHE-2106924</funding_grant_id><pubmed_authors>Castelli SL</pubmed_authors><pubmed_authors>Yu L</pubmed_authors><pubmed_authors>Noria SF</pubmed_authors><pubmed_authors>Ortiz M</pubmed_authors><pubmed_authors>Kowdley D</pubmed_authors><pubmed_authors>Needleman BJ</pubmed_authors><pubmed_authors>Rodriguez-Saona L</pubmed_authors><pubmed_authors>Lee A</pubmed_authors><pubmed_authors>Sellers P</pubmed_authors><pubmed_authors>Parquette JR</pubmed_authors><pubmed_authors>Pokharel B</pubmed_authors><pubmed_authors>Leung JH</pubmed_authors><pubmed_authors>Taneja S</pubmed_authors><pubmed_authors>Ganesan LP</pubmed_authors><pubmed_authors>Ziouzenkova O</pubmed_authors></additional><is_claimable>false</is_claimable><name>Bidirectional regulation of liver sinusoidal clearance by amino acid nanofibers and IGFBP4 complex: effects on HbA1c.</name><description>Therapies for type 2 diabetes primarily target hyperglycemia; however, complications are also triggered by advanced glycation end products (AGEs). We hypothesize that the anti-diabetic efficacy of insulin-like growth factor-binding protein 4 (IGFBP4) is enhanced when it assembles with a specific amino acid compound-2 (AAC2) into nanostructures. Their effects were examined in vitro and in ob/ob mice treated for 30 days with the AAC2-IGFBP4 complex or its individual components. IGFBP4-mediated glucose uptake in human and mouse preadipocytes was enhanced by complex formation with AAC2. This complex was confirmed by Fourier-transform mid-infrared spectroscopy, electrophoresis, and AFM. In ob/ob mice, the complex prolonged IGFBP4 circulation and amplified the effects of the individual component</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-16T07:09:53.101Z</modification><creation>2026-06-16T03:09:56.157Z</creation></dates><accession>S-EPMC12853802</accession><cross_references><pubmed>41454387</pubmed><doi>10.1186/s12951-025-03943-5</doi></cross_references></HashMap>